Cristian Alonso Duarte Carreño

Cristian Alonso Duarte Carreño

Auto-generated profile, based on publicly available information

Cristian Alonso Duarte Carreño

Clínica Medical Duarte

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in Educational Regent Multidisciplinary Journal
Verified
Journal Article
Open access
PDF file
CTCésar Eduardo Ceja Tovar
César Eduardo Ceja Tovar
JCJose Ruben Romero Castellares
Jose Ruben Romero Castellares
MGMario Alfonso Blanco Gomez
Mario Alfonso Blanco Gomez
JAJosé Enrique González Araujo
José Enrique González Araujo
ELErick Trejo López
Erick Trejo López
CCCristian Alonso Duarte Carreño
Cristian Alonso Duarte Carreño
Cardiovascular diseases (CVDs) remain the leading cause of death worldwide, yet conventional predictive models often fail to capture the complex interplay of genetic and physiological risk factors in diverse populations. This study evaluated a hybrid predictive model integrating polygenic risk scores (PRS), artificial intelligence (AI) applied to electrocardiography (ECG), and traditional clinical variables to enhance cardiovascular risk prediction across Latin American cohorts from Mexico, Colombia, and Ecuador. A total of 6,450 participants aged 30 to 75 years were analyzed. PRS were derived from genome-wide association data, and ECGs were processed using deep convolutional neural networks. Model performance was assessed using AUROC, F1-score, and calibration metrics, with interpretability achieved through SHAP (Shapley Additive Explanations) analysis. The hybrid model demonstrated superior predictive accuracy (AUROC 0.91; F1-score 0.87; calibration slope 0.97) compared with the clinical (0.72), PRS (0.78), and AI-ECG (0.86) models. The most influential predictors were PRS, systolic blood pressure, age, and AI-derived electrical age. Subgroup analyses revealed consistent performance across ancestries (Mestizo 0.91; Amerindian 0.89; European 0.93; Afro-descendant 0.87) and countries, confirming the model’s generalizability and fairness. These findings demonstrate that integrating genetic and AI-based physiological data significantly improves cardiovascular risk assessment, enabling early, equitable, and personalized prevention. The proposed hybrid framework provides a scalable foundation for implementing AI-driven genomic precision medicine in multi-ancestry populations, marking an essential step toward reducing cardiovascular disparities in Latin America.

10 December 2025 in IECCMEXICO
Verified
Journal Article
Closed access
JAJosé Enrique González Araujo
José Enrique González Araujo
YAYoleimys Lizeth Fuentes Araujo
Yoleimys Lizeth Fuentes Araujo
SGSebastián Felipe Peralta González
Sebastián Felipe Peralta González
JQJosé Uriel Cornejo Quezada
José Uriel Cornejo Quezada
CCCristian Alonso Duarte Carreño
Cristian Alonso Duarte Carreño
GZGiancarlo Ottelo Amory Zambrano
Giancarlo Ottelo Amory Zambrano
Multimorbidity has become a defining challenge for internal medicine, characterized by the coexistence of multiple chronic diseases and shaped by functional decline, treatment burden, and socioeconomic vulnerability. This review synthesizes contemporary evidence on the epidemiology, clinical consequences, and health-system implications of multimorbidity, with a particular focus on Mexico, Colombia, and Ecuador. Findings demonstrate steep age-related increases in prevalence, strong associations with mortality, hospitalization, disability, and elevated costs, and significant variability driven by methodological differences and inequities in access to care. Functional impairment consistently emerges as a central predictor of adverse outcomes, underscoring the need for geriatric-informed, person-centered approaches. Despite extensive observational research, interventional and policy-oriented studies remain limited, especially in middle-income settings. The review highlights the urgent need for integrated care models, improved coordination between internal medicine and primary care, and equity-oriented policies capable of responding to the complex trajectories of multimorbidity. By integrating theoretical, epidemiological, and health-system perspectives, this study provides a foundation for advancing research, guiding clinical decision-making, and informing system reforms in Latin American internal medicine.

1 September 2025 in Multidisciplinary Journal of Sciences, Discoveries, and Society
Verified
Journal Article
Open access
PDF file
RTRichard Adrian Vergara Trujillo
Richard Adrian Vergara Trujillo
RGRicardo Daniel Corona González
Ricardo Daniel Corona González
JAJosé Enrique González Araujo
José Enrique González Araujo
GRGiómar Adrián Crespo Rojas
Giómar Adrián Crespo Rojas
ICIssac Omar Morales Carlos
Issac Omar Morales Carlos
PPPaola Montserrat Zagaceta Perez
Paola Montserrat Zagaceta Perez
The increasing coexistence of multiple chronic conditions in aging populations has intensified the global challenge of polypharmacy, demanding a redefinition of internal medicine toward more integrated, patient-centered care. This multinational cross-sectional study examined the relationship between multimorbidity and polypharmacy among 1,260 adults aged ≥60 years in Mexico, Colombia, and Ecuador. Data were collected through standardized interviews and analyzed using descriptive and multivariate methods. Results revealed that 62.3% of participants had three or more chronic conditions and 65% met the criteria for polypharmacy (≥5 medications daily). The prevalence of adverse drug events (ADEs) increased proportionally with the number of medications, reaching 55% among participants taking nine or more drugs. Multivariate analysis identified ≥3 chronic diseases (aOR = 3.2), age ≥75 years (aOR = 1.9), low education (aOR = 1.7), and female sex (aOR = 1.4) as significant predictors of polypharmacy. Cross-country comparison showed higher institutional readiness in Mexico and Colombia, particularly in pharmacovigilance programs and clinical pharmacy access, though deprescribing practices and public awareness remained limited. Findings highlight the need for regional strategies to strengthen medication safety, promote deprescribing, and integrate pharmacists into multidisciplinary teams. Aligning with the United Nations Sustainable Development Goal 3, this study calls for the redesign of internal medicine to prioritize rational pharmacotherapy, equity, and patient well-being in the context of population aging.

3 December 2025 in IECCMEXICO
Verified
Journal Article
Closed access
JAJosé Enrique González Araujo
José Enrique González Araujo
JCJhonatan Nieto Centeno
Jhonatan Nieto Centeno
FMFrancisco Xavier Chavez Molina
Francisco Xavier Chavez Molina
CLCristian Camilo Cabrera Lugo
Cristian Camilo Cabrera Lugo
SMSayuri Ibeth Ramos Meneses
Sayuri Ibeth Ramos Meneses
CCCristian Alonso Duarte Carreño
Cristian Alonso Duarte Carreño
Cardiovascular risk stratification is undergoing a major paradigm shift driven by advances in genomics, inflammatory profiling, imaging biomarkers, myocardial injury detection, and artificial intelligence. This review integrates evidence from twenty high-impact studies to outline a multidimensional framework for precision cardiovascular risk assessment. Genomic tools, particularly polygenic risk scores, consistently demonstrate strong predictive value and highlight substantial inherited susceptibility that traditional models often fail to detect. Inflammatory and immunometabolic markers emerge as equally central determinants, underscoring the biological complexity of atherosclerosis and the relevance of chronic immune activation. Imaging techniques and high-sensitivity biomarkers provide additional layers of subclinical resolution, while AI-enhanced electrocardiography introduces new opportunities for early detection. A temporal analysis reveals a rapid expansion of precision-oriented research after 2018, culminating in a robust evidence base that favors integrative models over single-domain predictors. The proposed conceptual framework illustrates how these domains converge to generate a richer, individualized understanding of cardiovascular risk. The discussion emphasizes translational challenges and the need for equitable implementation in diverse populations, particularly in Mexico, Colombia, and Ecuador, where structural barriers may limit access to emerging precision tools. Overall, the findings support a shift toward biologically informed, technologically augmented, and context-adapted cardiovascular prevention strategies capable of improving predictive accuracy and advancing global cardiovascular health.